Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Celecoxib versus ketorolac following robotic hysterectomy for the management of postoperative pain: An open-label randomized control trial.

Ulm MA, ElNaggar AC, Tillmanns TD.

Gynecol Oncol. 2018 Oct;151(1):124-128. doi: 10.1016/j.ygyno.2018.08.015. Epub 2018 Aug 16.

PMID:
30121131
2.

Use of a web-based app to improve postoperative outcomes for patients receiving gynecological oncology care: A randomized controlled feasibility trial.

Graetz I, Anderson JN, McKillop CN, Stepanski EJ, Paladino AJ, Tillmanns TD.

Gynecol Oncol. 2018 Aug;150(2):311-317. doi: 10.1016/j.ygyno.2018.06.007. Epub 2018 Jun 11.

PMID:
29903391
3.

Fertility Preservation Through Oocyte Cryopreservation in a Patient with Ovarian Dysgerminocarcinoma: A Case Report.

Brezina PR, Ding J, Ke RW, Klosky JL, Tillmanns TD.

J Reprod Med. 2015 Sep-Oct;60(9-10):441-4.

PMID:
26592073
4.

Live full-term ovarian ectopic pregnancy: a case report.

Lee ML, Li BC, Robins D, Tillmanns TD.

J Reprod Med. 2014 Nov-Dec;59(11-12):607-10.

PMID:
25552137
5.

In vitro chemoresponse analysis of cervical cancer patient specimens.

Grigsby PW, Gan CM, Tillmanns TD, Del Priore G.

Int J Gynecol Cancer. 2014 Nov;24(9):1665-74. doi: 10.1097/IGC.0000000000000186.

PMID:
24987911
6.

Guided outcomes in learned efficiency model in clinical medical education: a randomized controlled trial of self-regulated learning.

Patil AS, Elnaggar AC, Kumar S, Ling FW, Stritter FT, Temiyakarn L, Tillmanns TD.

Am J Obstet Gynecol. 2014 Nov;211(5):544.e1-7. doi: 10.1016/j.ajog.2014.05.048. Epub 2014 Jun 4.

PMID:
24907703
7.

Combination metronomic oral topotecan and pazopanib: a pharmacokinetic study in patients with gynecological cancer.

Turner DC, Tillmanns TD, Harstead KE, Throm SL, Stewart CF.

Anticancer Res. 2013 Sep;33(9):3823-9.

8.

Outcomes of obese versus non-obese subjects undergoing robotic-assisted hysterectomy: a multi-institutional study.

Davenport WB, Lowe MP, Chamberlin DH, Kamelle SA, Johnson PR, Tyndall M, Tillmanns TD.

J Robot Surg. 2013 Mar;7(1):15-20. doi: 10.1007/s11701-011-0333-0. Epub 2012 Jan 19.

PMID:
27000887
9.

Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma.

Tillmanns TD, Lowe MP, Walker MS, Stepanski EJ, Schwartzberg LS.

Gynecol Oncol. 2013 Feb;128(2):221-8. doi: 10.1016/j.ygyno.2012.08.039. Epub 2012 Sep 5.

PMID:
22960352
10.

Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature.

Lowe MP, Kumar S, Johnson PR, Kamelle SA, Chamberlain DH, Tillmanns TD.

J Robot Surg. 2010 Aug;4(2):109-15. doi: 10.1007/s11701-010-0195-x. Epub 2010 Jun 11.

PMID:
27628776
11.

A multiinstitutional experience with robotic-assisted hysterectomy with staging for endometrial cancer.

Lowe MP, Johnson PR, Kamelle SA, Kumar S, Chamberlain DH, Tillmanns TD.

Obstet Gynecol. 2009 Aug;114(2 Pt 1):236-43. doi: 10.1097/AOG.0b013e3181af2a74.

PMID:
19622983
12.

Lymph node counts in uterine cancer: a randomized double blind trial.

Santoso JT, Azadi A, Wan J, Handorf C, Coleman RL, Tillmanns TD.

Gynecol Oncol. 2009 May;113(2):159-62. doi: 10.1016/j.ygyno.2009.02.001. Epub 2009 Mar 5.

PMID:
19268343
13.

A multi-institutional experience with robotic-assisted radical hysterectomy for early stage cervical cancer.

Lowe MP, Chamberlain DH, Kamelle SA, Johnson PR, Tillmanns TD.

Gynecol Oncol. 2009 May;113(2):191-4. doi: 10.1016/j.ygyno.2009.01.018. Epub 2009 Feb 26.

PMID:
19249082
14.

Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone.

Tillmanns TD, Falkner CA, Engle DB, Wan JY, Mannel RS, Walker JL, Johnson GA, McMeekin DS, Zuna R, Gold MA.

Gynecol Oncol. 2006 Feb;100(2):379-84.

PMID:
16321430
15.

Sensitization of cervical cancer cell lines to low-dose radiation by retinoic acid does not require functional p53.

Tillmanns TD, Kamelle SA, Guruswamy S, Gould NS, Rutledge TL, Benbrook DM.

Gynecol Oncol. 2005 Apr;97(1):142-50.

PMID:
15790450
16.

Cervical cancer guidelines. Clinical practice guidelines in oncology.

Teng N, Abu-Rustum NR, Bahador A, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Fiorica J, Greer BE, Kapp DS, Kavanagh J, Koh WJ, Kuettel M, Lurain JR, Molpus KL, Nag S, Partridge EE, Powell CB, Reynolds RK, Small W Jr, Soper J, Tillmanns TD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2004 Nov;2(6):612-30. No abstract available.

PMID:
19780304
17.

A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?

Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.

Gynecol Oncol. 2004 Oct;95(1):70-6.

PMID:
15385112
18.

Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?

Kamelle SA, Rutledge TL, Tillmanns TD, Gould NS, Cohn DE, Wright J, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.

Gynecol Oncol. 2004 Aug;94(2):249-55.

PMID:
15297159
19.

Ovarian cancer metastatic to the brain: what is the optimal management?

McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS.

J Surg Oncol. 2001 Nov;78(3):194-200; discussion 200-1. Review.

PMID:
11745806
20.

Panniculectomy with simultaneous gynecologic oncology surgery.

Tillmanns TD, Kamelle SA, Abudayyeh I, McMeekin SD, Gold MA, Korkos TG, Johnson PR.

Gynecol Oncol. 2001 Dec;83(3):518-22.

PMID:
11733965

Supplemental Content

Loading ...
Support Center